Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Vinorelbine plus Bevacizumab in Metastatic Breast Cancer
NCT00694200Phase 2Terminated
- Sponsor
- Hellenic Oncology Research Group
- Start
- Apr 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of vinorelbine, bevacizumab in breast cancer, sponsored by Hellenic Oncology Research Group. Started Apr 2008; status: terminated.
02
Drugs
vinorelbinebevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00694200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00694200.